Tytuł pozycji:
Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis.
-
Tytuł:
-
Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis.
-
Autorzy:
-
Luo, Chengxin
Wu, Guixian
Huang, Xiangtao
Ma, Yanni
Zhang, Yali
Song, Qiuyue
Xie, Mingling
Sun, Yanni
Huang, Yarui
Huang, Zhen
Hou, Yu
Xu, Shuangnian
Chen, Jieping
Li, Xi
-
Źródło:
-
Scientific Reports. 2/5/2021, Vol. 11 Issue 1, p1-14. 14p.
-
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.